BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16302251)

  • 1. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
    Arbyn M; Schenck U; Ellison E; Hanselaar A
    Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of cytotechnologists' parameters with their performance in rapid prescreening of papanicolaou smears.
    Djemli A; Khetani K; Case BW; Auger M
    Cancer; 2006 Oct; 108(5):306-10. PubMed ID: 16948125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
    Kanber Y; Charbonneau M; Auger M
    Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
    Rowe LR; Marshall CJ; Bentz JS
    Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid prescreening as a quality assurance measure in cervical cytology.
    Repse-Fokter A; Caks-Golec T
    Acta Cytol; 2009; 53(3):268-70. PubMed ID: 19534265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer; 2008 Jun; 114(3):165-70. PubMed ID: 18454462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of rapid prescreening and 10% rescreening in liquid-based Papanicolaou testing.
    Currens HS; Nejkauf K; Wagner L; Raab SS
    Am J Clin Pathol; 2012 Jan; 137(1):150-5. PubMed ID: 22180489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid prescreen of cervical liquid-based cytology preparations: results of a study in an academic medical center.
    Frable WJ; Pedigo MA; Powers CN; Yarrell C; Ortiz B; Clark ME; Ebron T
    Diagn Cytopathol; 2012 Aug; 40(8):691-7. PubMed ID: 22807384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
    Linder J; Zahniser D
    Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
    Wilgenbusch H; Mueller G; Neal M; Renshaw AA
    Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
    Duncan L; Jacob S; Hubbard E
    Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P
    J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Renshaw A
    Cancer; 2006 Aug; 108(4):267; author reply 268. PubMed ID: 16671112
    [No Abstract]   [Full Text] [Related]  

  • 19. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated screening for quality control using PAPNET: a study of 638 negative Pap smears.
    Keyhani-Rofagha S; Palma T; O'Toole RV
    Diagn Cytopathol; 1996 Jun; 14(4):316-20. PubMed ID: 8725131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.